Kyrgyzstan Medical Device Distribution Licensing: Wholesale and Retail Requirements 2026

1. Key takeaways

Kyrgyzstan imposes licensing requirements on the distribution stage: wholesale and retail trade in devices requires a license issued by the regulatory body. The entities entitled to sell devices are also specific: the manufacturer, the authorized representative of the manufacturer, and qualified wholesale and retail enterprises. This means that selling devices in Kyrgyzstan is not merely a matter of the product holding a registration certificate; the seller must also hold the qualification. Both conditions must be met simultaneously for distribution to be lawful.

2. Legal basis

1. Law of the Kyrgyz Republic on the Circulation of Medical Devices, Law No. 216 of December 29, 2023: licensing requirements in the distribution stage and the qualifications of trading entities.
2. Law No. 216, Article 29: import requires a national register entry or an import permit conclusion.
3. Law No. 216, Article 31: circumstances prohibiting import.
4. Cabinet Resolution No. 450, June 29, 2026: inspection procedures in the field of medical device circulation.
5. Cabinet Resolution No. 513, August 27, 2024, Annex 2: procedures for safety, quality, and effectiveness surveillance.

Source note: the specific conditions of distribution licensing, the licensing authority, and the processing procedure were not available this cycle in official detail capable of verbatim citation. The statements below are made at the level of principle; concrete application is governed by the current legislation.

3. Expert insights

Insight 1: registration and distribution are two separate qualifications, and neither substitutes for the other.

A registration certificate answers whether the device may enter the market; a distribution license answers whether the enterprise may sell devices. The two are parallel conditions. The mistake Chinese manufacturers commonly make is to assume that handing goods to a local distributor settles everything, without verifying whether the distributor holds a distribution license. If the distributor operates without a license, both the manufacturer and the authorized representative become entangled in a distribution violation.

Insight 2: the three-way classification of entitled sellers effectively fixes the channel structure.

The law limits the entities entitled to sell to three: the manufacturer, the manufacturer’s authorized representative, and qualified wholesale and retail enterprises. This means a trading company without qualifications cannot lawfully sell even after taking delivery of the goods. We recommend making the holding of a distribution license a hard condition of distributor onboarding, with the license documents retained on file.

Insight 3: the entity consistency between the distribution license and the registration certificate is checked.

Cabinet Resolution No. 450 extends inspections to the distribution stage. During an inspection, the authorities verify whether the seller holds a license, whether the products sold hold registration certificates, whether labeling matches the registration dossier, and whether authorized representative information is up to date. Any one of the four items falling out of line produces a non-conformity. We recommend that the authorized representative build channel files and periodically verify the license status of distributors.

Insight 4: wholesale and retail are two license types covering different stages.

The licenses under the law divide into wholesale and retail types. Importers and regional distributors typically need the wholesale license; pharmacies and medical device stores selling to end users need the retail license. When designing the channel structure, companies should confirm, stage by stage, that each entity’s license type matches its role.

Insight 5: distribution compliance connects head-to-tail with post-market obligations.

Distribution is the last stage before products reach users, and it is the first source of post-market surveillance information, including complaints, adverse events, and quality issues. We recommend merging distributor license management with post-market information collection, with the authorized representative maintaining channel files in a unified way. This serves distribution compliance and simultaneously forms the entry point of the surveillance system (see Parts 41 and 42 of this series).

4. Practical recommendations

First, make the holding of a distribution license a hard condition of distributor onboarding. We recommend adding a licensing clause to distribution agreements: the distributor must hold a distribution license matching the stage of sale and provide an updated version before expiry, and the agreement suspends automatically if the license lapses.

Second, build channel files and verify them periodically. We recommend that the authorized representative maintain distributor files covering entity information, license type and number, validity period, covered territory, and the list of products sold, verified once per quarter.

Third, confirm license type matches role, stage by stage. We recommend clarifying each entity’s role in the channel design, whether importer, wholesaler, or retailer, and checking that the license type held matches that role.

Fourth, merge channel files with post-market information collection. We recommend adding information-collection fields to the channel files, including complaint contacts and adverse event reporting paths, so that distribution compliance and the surveillance system share one dataset.

Fifth, prepare a distribution-stage materials pack for inspections. We recommend adding a distribution section to the inspection readiness kit: the list of distributor licenses, supply records, traceability records, and complaint and vigilance files (see Part 16 of this series).

5. Verification checklist

• □ Confirmed that a licensing requirement exists at the distribution stage, with wholesale and retail licensed separately;
• □ Distribution agreements contain a licensing clause: license-holding requirement, renewal duty, and automatic suspension upon lapse;
• □ Distributor channel files established, covering entity information, license type and number, validity period, covered territory, and the product list;
• □ License types have been checked against roles stage by stage, whether importer, wholesaler, or retailer;
• □ Channel files are merged with post-market information collection, including complaint contacts and adverse event reporting paths;
• □ The inspection readiness kit includes a distribution section: distributor license list, supply records, traceability records, and complaint and vigilance files.

Regulatory information verified as of October 29, 2026.

Our services cover pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, manufacturing site inspection coordination, quality management system compliance coaching, post-market surveillance and vigilance system setup, import and distribution compliance, state fee estimation, and project budget management.

The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registrations. It maintains a stable local cooperation network in Bishkek, Almaty, Tashkent, Moscow, and other cities, and works in Chinese, Russian, and English. For the key issues that foreign manufacturers commonly face in CIS markets, including authorized representative arrangements, the notarization and legalization chain for powers of attorney, localization of technical documentation, and inspection response, GRZAN provides executable solutions.

We hold to one principle: every regulatory conclusion we publish must be traceable to verifiable official sources. Any figure or timeline that cannot be verified is always labeled as a practical estimate, and experience values are never presented as legal grounds.

GRZAN provides registration and compliance support in Kyrgyzstan for medical device manufacturers, importers, and authorized representatives. For project consultation on market access in Kyrgyzstan or the Eurasian Economic Union, please contact us at info@grzanglobal.com.

GRZAN | Global Medical Device Regulatory Registration and Compliance Services